Last reviewed · How we verify

NCT02707718: BIPS

Biomarkers for the Early Identification of Sepsis in the Emergency Department

Completed Last updated 17 April 2018
What this trial tests

trial testing blood sampling in Sepsis in 320 participants. Completed in 3 March 2018.

Timeline
1 March 2016
Primary endpoint
3 March 2018
3 March 2018

Quick facts

Lead sponsorPitié-Salpêtrière Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment320
Start date1 March 2016
Primary completion3 March 2018
Estimated completion3 March 2018
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Pitié-Salpêtrière Hospital

Who can join

Adults 18 to 100, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Monocentric prospective study on consecutive patients attending the emergency department and suspected to have sepsis. Blood sampling for the measurement of a panel of biomarkers of interest in sepsis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of blood sampling

Trials testing the same drug.

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Pitié-Salpêtrière Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02707718.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing